GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (STU:8BD) » Definitions » EV-to-FCF

Boule Diagnostics AB (STU:8BD) EV-to-FCF : -20.68 (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Boule Diagnostics AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Boule Diagnostics AB's Enterprise Value is €43.56 Mil. Boule Diagnostics AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was €-2.11 Mil. Therefore, Boule Diagnostics AB's EV-to-FCF for today is -20.68.

The historical rank and industry rank for Boule Diagnostics AB's EV-to-FCF or its related term are showing as below:

STU:8BD' s EV-to-FCF Range Over the Past 10 Years
Min: -653   Med: 18.94   Max: 559.3
Current: -21.01

During the past 13 years, the highest EV-to-FCF of Boule Diagnostics AB was 559.30. The lowest was -653.00. And the median was 18.94.

STU:8BD's EV-to-FCF is ranked worse than
100% of 374 companies
in the Medical Devices & Instruments industry
Industry Median: 28.73 vs STU:8BD: -21.01

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-13), Boule Diagnostics AB's stock price is €0.72. Boule Diagnostics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.483. Therefore, Boule Diagnostics AB's PE Ratio (TTM) for today is At Loss.


Boule Diagnostics AB EV-to-FCF Historical Data

The historical data trend for Boule Diagnostics AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB EV-to-FCF Chart

Boule Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 244.79 42.69 -81.37 -7.87 -18.02

Boule Diagnostics AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.59 -18.02 -35.02 -72.02 -21.30

Competitive Comparison of Boule Diagnostics AB's EV-to-FCF

For the Medical Devices subindustry, Boule Diagnostics AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's EV-to-FCF falls into.



Boule Diagnostics AB EV-to-FCF Calculation

Boule Diagnostics AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=43.561/-2.106
=-20.68

Boule Diagnostics AB's current Enterprise Value is €43.56 Mil.
Boule Diagnostics AB's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boule Diagnostics AB  (STU:8BD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Boule Diagnostics AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.72/-0.483
=At Loss

Boule Diagnostics AB's share price for today is €0.72.
Boule Diagnostics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.483.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Boule Diagnostics AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB Business Description

Traded in Other Exchanges
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB Headlines

No Headlines